Biome Australia LtdASX: BIO

Ethics Approval Granted for BMB18 Human Clinical Trial

· Issued by Biome Australia Ltd

Filed with ASX · · 5 pages · English

● Randomised, double-blind, placebo-controlled trial recruiting 240 participants to investigate the efficacy of proprietary strain Lactobacillus plantarum BMB18 (DSM 35214) in adults experiencing digestive symptoms, sleep and mood disturbances ● La Trobe University Human Research Ethics Committee grants ethics approval, clearing the final regulatory prerequisite for the trial to commence in Februa

Biome Australia Ltd on 6ix

Story so far

Earlier from Biome Australia

Later from Biome Australia

All Biome Australia news releases